(Q40885079)

English

The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mycobacterium tuberculosis

0 references

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Gebremedhin Gebremicael

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Debbie van Baarle

11

object named as

Debbie van Baarle

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tsehaynesh Messele

8

object named as

Tsehaynesh Messele

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tom H M Ottenhoff

10

object named as

Tom H M Ottenhoff

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

object named as

Desta Kassa

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Yodit Alemayehu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Leonie Ran

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Justin Fransen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Dawit Wolday

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Belete Tegbaru

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

30 September 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

96

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

131-140

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Vaccines against tuberculosis: where are we and where do we need to go?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

New diagnostic tests for tuberculosis: bench, bedside, and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Biomarkers of disease activity, cure, and relapse in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immunological biomarkers of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Into the eye of the cytokine storm

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Cell-mediated immune responses in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Depressed T‐Cell Interferon‐γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Specific cytokine patterns of pulmonary tuberculosis in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Tuberculosis After Commencing Antiretroviral Therapy for HIV Infection Is Associated With Elevated CXCL9 and CXCL10 Responses to Mycobacterium tuberculosis Antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Tuberculosis in Africa: learning from pathogenesis for biomarker identification

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40885079&oldid=2142988896"